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ABSTRACT
We have conducted first-principles and classical molecular dynamics simula-
tions of various compositions of strontium-containing phosphate glasses, to
understand how strontium incorporation will change the glasses’ activity when
implanted into the body (bioactivity). To perform the classical simulations, we
have developed a new interatomic potential, which takes account of the polar-
izability of the oxygen ions. The Sr–O bond length is *2.44–2.49 A˚, and the
coordination number is 7.5–7.8. The Qn distribution and network connectivity
were roughly constant for these compositions. Sr bonds to a similar number of
phosphate chains as Ca does; based on our previous work (Christie et al. in J
Phys Chem B 117:10652, 2013), this implies that SrO $ CaO substitution will
barely change the dissolution rate of these glasses and that the bioactivity will
remain essentially constant. Strontium could therefore be incorporated into
phosphate glass for biomedical applications.
Introduction
Strontium is of profound importance in biomedical
science [1], particularly because of its effect on bone
growth. Strontium is naturally occurring in the
human body, although at very low quantities, where
it acts as a ‘‘bone seeker’’ like calcium, to the point
that *99% of the body’s strontium is found in bone.
Strontium is known to act synergistically with cal-
cium to promote osteoblastic bone formation as well
as inhibiting osteoclastic bone resorption [2]. As a
result, strontium ranelate is an approved treatment
for osteoporosis in postmenopausal women [3–6],
who have an increased prevalence of the disease,
whereas strontium malonate is currently undergoing
clinical trials. Strontium intake also leads to greater
deposition of calcium in bone [1]. Other medical uses
of strontium include exploiting its bactericidal nature
for injectable bone cement [7] and as an adjunct to
radiotherapy [8].
In recent years, there has been substantial interest
in incorporating strontium into other therapeutic
materials which are implanted into the body. The
dissolution products of many such materials are also
known to promote new bone growth [9, 10]. Experi-
mental [11, 12] and computational [13, 14] studies on
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strontium-containing bioglass have shown that the
effect of strontium inclusion on the atomic structure
is rather small, even for quite large (B25%) concen-
trations of SrO [15]. However, the inclusion of Sr
decreases bioactivity by decreasing the apatite-form-
ing ability and dissolution rate [12] of bioglass.
Phosphate-based bioactive glasses (PBG) are also of
considerable medical use, particularly because their
dissolution rate is much faster than that of silicate-
based glasses, and this rate can be tuned over several
orders of magnitude by changes in the glass com-
position [9, 16]. This allows for the possibility of
delivery of therapeutic ions to a localised site in the
body at an appropriate rate, for the control of bone
growth [10] among other treatments. It is natural
therefore to ask whether Sr’s osteogenic properties
could be combined with the favourable dissolution
behaviour of PBG. To do this, however, we need to
know the effect of strontium inclusion on the struc-
ture and degradation properties of PBG.
When Sr2? was incorporated into (P2O5)50–
(Na2O)20–(CaO)30 glasses, a disproportionation of Q
2
phosphorous atoms was seen, decreasing their
prevalence and increasing the amount of Q1 and Q3
species [17]. Unexpectedly, the glass degradation rate
increased with the addition of 1 mol% SrO (in place
of Na2O) and then decreased with the addition of
3–5 mol% SrO, but it seems likely that this is due to
varying phosphate contents (Table 4, Ref. [17]) in the
prepared Sr-containing glasses, rather than any effect
of the Sr itself. However, SrO substitution for CaO in
Ti-containing ternary metaphosphate glasses seemed
to show similar properties, with an increase by an
order of magnitude in the degradation rate going
from Sr-free to 1 mol% SrO, and then a slight
decrease for SrO contents up to 5 mol%, with similar
trends exhibited for ion release [18, 19]. The Sr-con-
taining glasses were also found to be biocompatible,
with excellent cell attachment and growth properties.
It is clear that the precise effect of strontium
inclusion on phosphate-based bioactive glasses is not
fully understood. If Sr-containing PBGs are to be
used for the controlled release of therapeutic ions,
then the connections between the glass composition,
atomic structure and macroscopic properties such as
degradation rate and cell adhesion must be under-
stood, and computer simulation offers a route to
achieve this goal. Molecular dynamics (MD) simula-
tions provide the atomic structure of the glass, as well
as enabling computation of large-scale materials
properties. We and others have previously used MD
simulations to elucidate the connection between
atomic structure and dissolution behaviour of a
variety of silicate [20–27] and phosphate glasses
[28–30] intended for implantation, including stron-
tium-containing silicate glass [13, 14]. However, there
have been no simulations of Sr in phosphate glass.
In MD, the positions of the atoms evolve under
Newton’s laws of motion. First-principles MD relies
on a quantum–mechanical description of the inter-
atomic forces, provided here through density func-
tional theory (DFT). Although very accurate, the
computational expense of such simulations is very
high, and they are therefore limited to small models
(a few hundreds of atoms) and short timescales. In
classical MD, the interatomic forces are approximated
by an empirical potential which is easier to compute,
permitting the simulation of much larger models for
longer timescales, but at the cost of introducing
approximations and losing information on the elec-
tronic structure. It is therefore vital to derive a
potential that is as accurate as possible. Previous
simulations of Sr-containing silicate glasses [13, 14]
have used a rigid-ion interatomic potential, in which
the ions have partial charges and the polarizability of
the ions is not included. Although this can often give
satisfactory agreement with experimental data [22], it
has been shown [31] that using a potential which
incorporates the polarizability of the oxygen atoms,
typically using the shell model, provides a more
accurate representation of the medium-range struc-
ture of glasses, particularly the network connectivity
and Qn distribution. The network connectivity, Qn
distribution [21] and other medium-range structural
motifs [28] are known to affect the bioactivity sub-
stantially. It is therefore essential that in any simu-
lation, they are described correctly. We have
therefore developed a polarizable potential for
strontium, which is compatible with other potentials
[32], and will offer an accurate description of the
relevant structures and properties.
We have shown [28] that for polyphosphate
(\50 mol% P2O5) glasses, in which the PO4 phos-
phate tetrahedra form finite-length unbranched
chains, the dissolution rate is largely controlled by
the interactions between these phosphate chains and
the network-modifying cations (e.g., Na, Ca) to which
they are bound. Ca binds to more chains than Na,
and this strongly contributes to the known decrease
in degradation rate [9] when Ca is substituted for Na,
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by strengthening the glass network. Since these
compositions are commonly used [9], a full descrip-
tion of the effect of strontium inclusion on the dis-
solution of these glasses must therefore include its
bonding to these chains.
In this work, we use classical and first-principles
molecular dynamics to simulate several compositions
of Sr-containing phosphate-based glasses. Following
a description of the construction and validation of the
new strontium potential, we describe the short-range
structural environment around strontium, in terms of
bond lengths, coordination environment and bond
angles, before moving on to discuss the effect of
strontium inclusion on the Qn distribution and net-
work connectivity. We conclude with a discussion of
strontium’s effect on the suitability of the glass for
biomedical implantation.
Development of a strontium interatomic
potential
We sought to develop an accurate interatomic
potential to take account of the inclusion of strontium
into the glass structure. In our classical MD simula-
tions, the interatomic interactions are described by
the Born model of solids using full-charge pair
potentials. In addition to the electrostatic interactions
between ions, the short-range interactions are mod-
elled by the Buckingham potential Vij rð Þ ¼ Aij
exp r
.
qij
 
 Cij

r6, where r is the interatomic dis-
tance between atoms of species i and j and Aij, qij and
Cij are the parameters of the model. Our criteria were
to develop a potential compatible with previous
polarizable potentials developed for both phosphate
[32] and silicate [33] glasses, so that it could be used
to model the strontium environment in both types of
glasses. (This work studies only phosphate glasses; Sr
in silicate glasses will be the subject of future work.)
The GULP code [34] was used to fit the Sr–Os
Buckingham potential to reproduce the crystal
structures of SrO [35], SrSiO3 [36], Sr2SiO4 [37] and
Sr3(PO4)2 [38], i.e., including oxide, silicate and
phosphate environments. The other potential inter-
actions were held constant to the values (Table 1)
which have previously been used to model a wide
range of silicate and phosphate glasses [32, 39]. The
final potential parameters are listed in Table 1, and
the lattice parameters of the crystalline structures are
given in Table 2.
It is clear that the Sr–Os potential works well in
diverse oxide environments, as none of the errors in
the lattice parameters or bond angles is larger than
2.7%, and most are considerably smaller. Moreover,
the potential performs better, in the sense that the
Table 1 The interatomic potential parameters used in this work
Pairs A (eV) q (A˚) C (eV A˚6)
V ¼ Aij exp r
.
qij
 
 Cij

r6
Sr–Os 2472.714957 0.314337 0.121766
Na–Os [33] 56465.3453 0.193931 0.0
Ca–Os [33] 2152.3566 0.309227 0.09944
P–Os [32] 1020.00 0.343220 0.03
Os–Os [39] 22764.30 0.149 27.88
Triplets k3b (eV rad
-2) h0 ()
k3b hjik  h0
 2
Os–P–Os [32] 3.3588 109.47
P–Os–P [32] 7.6346 141.1793
Os–Si–Os [33] 2.097 109.47
Core-shell kcs q (Oc)
kcs r Ocð Þ  r Osð Þð Þ2
Oc–Os [39] 74.92 ?0.8482
Table 2 The calculated and experimental lattice parameters for
strontium crystals using the interatomic potentials developed in
this work
Material Parameter Calc. Exp. Diff.
Sr3(PO4)2 a, b 5.491 A˚ 5.378 A˚ ?2.1%
c 19.561 A˚ 19.754 A˚ -1.0%
a, b 90.0
c 120.0
SrO a, b, c 5.018 A˚ 5.156 A˚ -2.7%
a, b, c 90.0
SrSiO3 a 12.286 A˚ 12.333 A˚ -0.4%
b 7.147 A˚ 7.146 A˚ ?0.0%
c 10.960 A˚ 10.885 A˚ ?0.7%
a, c 90.0
b 110.87 111.57 -0.6%
Sr2SiO4 a 9.756 A˚ 9.767 A˚ -0.1%
b 7.093 A˚ 7.084 A˚ ?0.1%
c 11.061 A˚ 11.059 A˚ ?0.0%
a, c 90.0
b 148.89 149.24 -0.2%
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errors are smaller, in the silicate and phosphate
environments in which it is intended to be used.
Methods
Our interatomic potential was used in the DLPOLY
code [40] to conduct classical MD simulations of a
variety of compositions of strontium-containing
phosphate glasses based on compositions with
45 mol% P2O5, 25 mol% Na2O and 30 mol% CaO,
which have been studied both experimentally [17]
and in simulation [28]. SrO was substituted both for
CaO (the other alkaline earth oxide) and for Na2O to
facilitate a comparison to experimental data. The
precise compositions and densities studied are given
in Table 3. Classical MD was performed on the
compositions with 1 and 3 mol% SrO, and for each of
these compositions, about 3000 atoms were placed
independently and randomly into a cubic periodic
box to give the appropriate density (Table 3) subject
only to the constraint that atoms not be placed closer
than 85–90% of their expected interatomic distances
to avoid unphysical starting configurations. Three
independent configurations were prepared for each
of these compositions. Following an instantaneous
relaxation at zero temperature, the classical models
were run in an NVT ensemble for 50 ps at 2500 K,
before being cooled in a series of runs in NVT
ensembles of length 50 ps, decreasing the tempera-
ture by 200 K in each run, at a cooling rate of 4 K/ps.
The model was then run in an NVT ensemble at
300 K for 200 ps, the final two-thirds of which formed
the production run. Unless otherwise stated, all data
are averaged over snapshots taken from this pro-
duction run and over the three independent models.
The timestep was 0.2 fs, and the potentials were
truncated at 8 A˚. The Ewald cut-off was 12 A˚.
First-principles molecular dynamics, in which the
interatomic forces are derived from a quantum–
mechanical representation of the electronic structure,
was performed on the compositions with 10 mol%
SrO (Table 3). Due to the greater computational
expense of these simulations, they can only be per-
formed on relatively small models and for shorter
timescales. In order to ensure adequate sampling of
the strontium environment, therefore, two compo-
sitions with this rather high SrO content were
modelled. The CP2K code [41] was used to perform
Born–Oppenheimer molecular dynamics on these
systems. For each composition, about 150 atoms
were placed independently and randomly into a
cubic periodic box to give the appropriate density
(Table 3) again subject to the constraint that atoms
not be placed closer than 85–90% of their expected
interatomic distances. The models were then run in
an NVT ensemble at 2500 K for 20 ps, before being
cooled in a series of runs in NVT ensembles of
length 10 ps, decreasing the temperature by about
300 K in each run, corresponding to a cooling rate of
*30 K/ps. The models were then run in an NVT
ensemble at 300 K for *40–50 ps, the final two-
thirds of which formed the production run. Unless
otherwise stated, all data are averaged over snap-
shots taken from this production run. The plane-
wave cut-off was 600 eV, and the timestep was
1.0 fs. PBE [42] exchange–correlation functionals in
the generalised gradient approximation (GGA) were
used.
Although the cooling rates for both classical and
first-principles models are much faster than those
used experimentally, models prepared using these
methodologies have given structures in agreement
with experiment for silicate [20, 43–45] and phos-
phate glasses [28, 46], including for compositions
intended for implantation.
Table 3 The glass
compositions, densities and
numbers of atoms studied in
this work
Name Mol% Density Numbers of atoms
P2O5 Na2O CaO SrO (g/cm
3) O P Na Ca Sr
P45NSr1 45.0 24.0 30.0 1.0 2.57 1872 602 320 200 7
P45NSr3 45.0 22.0 30.0 3.0 2.58 1879 604 296 201 20
P45CSr1 45.0 25.0 29.0 1.0 2.57 1867 600 334 193 7
P45CSr3 45.0 25.0 27.0 3.0 2.58 1867 600 334 180 20
P45NSr10 45.0 15.0 30.0 10.0 2.64 93 30 10 10 3
P45CSr10 45.0 25.0 20.0 10.0 2.64 93 30 16 7 3
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Results
The relationships between the structure and bioac-
tivity of strontium-free phosphate-based glasses have
been discussed elsewhere [9, 16, 28]. Therefore, in this
work, we concentrate on characterising the strontium
environment.
Table 4 shows the bond lengths and coordination
numbers for each composition. The Sr–O bond
lengths for the classical models are between 2.44 and
2.49 A˚; those for the first-principles models are
slightly longer at 2.55–2.57 A˚. The generalised gra-
dient approximation (GGA) [42] which we have used
is known to underbind certain bonds, which would
lead to longer bond lengths, and it seems that this is
happening here.
Coordination numbers vary from 7.5 to 7.8 for the
classical models and are slightly larger for the first-
principles models, which is likely due to the longer
bond lengths as discussed above. Both the Sr–O bond
lengths and coordination numbers are larger than the
Na–O and Ca–O bond lengths and coordination
numbers, which has profound effects on the bioac-
tivity, as explained later. Figure 1 shows partial pair-
correlation functions for the three metal–oxygen pairs
in a representative composition, which also shows
clearly the larger cut-off needed to define the first
coordination shell of strontium.
Experimental estimates of the Sr–O bond length
and coordination number have not been performed
in phosphate glasses, to the best of our knowledge,
although the bond lengths we find are in good
agreement with those from strontium borosilicate
glass (2.52 A˚) [47] and strontium tin silicate glass
(2.59–2.64 A˚) [48]. The Sr–O coordination number
was between four and five in the borosilicate glass, in
contradiction to our results, but it was between seven
and eight for the tin silicate glass and around seven in
other computational studies [13, 14].
Some oxygen atoms are bound to two phosphorus
atoms, bridging two PO4 tetrahedra; these are known
as bridging oxygen (BO) atoms. Modifier ions prefer
to bond to non-bridging oxygen (NBO) atoms, which
typically carry a greater charge. When there is more
than one modifier atom in a glass composition, they
compete for these NBOs, leading to different
amounts of bonding to BO and NBO atoms for dif-
ferent modifiers [49]. In our models, the amounts of
NBO bound to each modifier are shown in Table 5.
For all compositions and methodologies, Na has the
smallest percentage of NBOs, and Ca the most, with
Sr between the two.
The bond-angle distribution around the modifier
atoms also reveals something of their local environ-
ments. As before, there is little difference between
compositions, at least for those simulated with the
Table 4 The Sr–O bond lengths and coordination numbers (using
a cut-off of 3.5 A˚) for the compositions studied
Name Bond length (A˚) Coordination number
P45NSr1 (2.45 ± 0.04) 7.8 ± 0.5
P45NSr3 (2.44 ± 0.02) 7.6 ± 0.1
P45CSr1 (2.49 ± 0.04) 7.5 ± 0.5
P45CSr3 (2.46 ± 0.02) 7.5 ± 0.2
P45NSr10 2.55 8.0
P45CSr10 2.57 8.7
Errors quoted are SDs from the independent conﬁgurations
Figure 1 The partial pair-correlation functions gNaO(r), gCaO(r) and
gSrO(r) for one model of P45CSr3, as a representative composition.
Coordination numbers are included in the legend; the cut-offs are 3.2 A
for Na–O and Ca–O and 3.5 A˚ for Sr–O.
Table 5 The percentage of non-bridging oxygen atoms in the ﬁrst
coordination shell of the modiﬁer atoms for all compositions
Name NBO neighbours
Na (%) Sr (%) Ca (%)
P45NSr1 (80 ± 1) (86 ± 4) (93 ± 1)
P45NSr3 (80 ± 1) (87 ± 2) (93 ± 1)
P45CSr1 (80 ± 0) (91 ± 1) (94 ± 0)
P45CSr3 (80 ± 0) (87 ± 1) (94 ± 1)
P45NSr10 86 89 95
P45CSr10 83 88 92
Errors quoted are SDs from the independent conﬁgurations
9018 J Mater Sci (2017) 52:9014–9022
same methodology. In Fig. 2, the O–M–O bond-angle
distribution, where M = Na, Ca or Sr, is displayed
for a representative composition. For each distribu-
tion, a very broad distribution of bond angles is seen,
reflecting the range of coordination environments
and the disorder inherent in the structure. The O–Sr–
O bond-angle distribution extends to more acute
bond angles than the other two, reflecting strontium’s
higher coordination number and the need for more
acute bond angles to accommodate seven or even
eight oxygen atoms in the coordination shell. All
three distributions have a broad peak at about 90,
corresponding to a distorted octahedral coordination
shell typical of six-coordinated atoms. For O–Sr–O,
this peak is at more acute angles because of the
greater number of higher-coordinated atoms.
One of the key parameters which controls the
bioactivity of glasses implanted into the human body
is the network connectivity [21], defined as the
average number of bridging oxygen (BO) atoms per
phosphorus atom. CaO $ SrO substitution is
thought unlikely to change the network connectivity
or Qn distribution (n is the number of BOs) because
the ratio of O atoms to P atoms remains constant. We
computed the Qn distribution for the compositions
prepared with classical MD to find that they were all
almost identical, with 26–27% Q1, 68–70% Q2, and 4%
Q3 for a network connectivity of 1.77–1.78.
In previouswork [28], we and others have identified
that one of the most relevant structural features for
glasses with\50 mol% P2O5 (equivalently, phosphate
glasses with a network connectivity less than 2) is the
extent to which the modifier ions bind to different
numbers of phosphate chains. We are able to compute
this for the three different modifier ions present in our
compositions here, and these results are presented in
Table 6. There is a clear difference between the 3.2–3.3
phosphate chains bound to the singly charged sodium
ion, and the 3.9 or more chains bound to the doubly
charged calcium and strontium ions, as we identified
previously for Sr-free glasses [28]. Sr seems to have a
similar number—perhaps very slightly larger—of
chains bound to it as are bound to Ca.
Discussion
We have investigated the effects caused by the
incorporation of strontium, which has osteogenic and
other useful medical properties, into bioactive phos-
phate glasses, which have a tunable dissolution rate.
We have focussed on understanding how strontium
changes the atomic structure, and how this is likely to
affect the bioactivity.
To do this, we had to develop an accurate potential
to represent the interatomic forces involving stron-
tium. The structural features in glasses which most
affect the bioactivity are known to occur at the
medium-range length scales, i.e., the network con-
nectivity, Qn distribution [21] and phosphate-chain to
network-modifier bonding [28]. It is also known that
to describe this medium-range structure well using
classical molecular dynamics simulations requires a
polarizable potential [31]. In order to maximise its
utility, therefore, we have developed a polarizable
potential that is compatible with previous work in
both phosphate and silicate glasses, and we have
shown that this potential model represented the
crystal structures of strontium oxide, silicates and
phosphate, rather well.
Using this new potential, we have shown that the
Sr–O bond length is *2.44–2.49 A˚ and the
Table 6 The average number of fragments bound to each Na, Ca
or Sr atom for the glass compositions studied
No. of fragments
Na Sr Ca
P45NSr1 3.2 ± 0.1 3.9 ± 0.2 3.9 ± 0.1
P45NSr3 3.2 ± 0.1 4.0 ± 0.1 3.9 ± 0.0
P45CSr1 3.2 ± 0.0 4.1 ± 0.5 3.9 ± 0.1
P45CSr3 3.3 ± 0.0 4.1 ± 0.2 4.0 ± 0.1
Errors quoted are SDs from the independent conﬁgurations
Figure 2 The O–Na–O (black), O–Ca–O (red) and O–Sr–O
(green) bond-angle distributions for one model of P45NSr3, as a
representative composition. The cut-offs are 3.2 A˚ for Na–O and
Ca–O and 3.5 A˚ for Sr–O.
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coordination number is 7.5–7.8; both of these quan-
tities are larger than for Na–O or Ca–O, which have
typical coordination numbers of less than seven.
Although all three modifier ions prefer to bond to
non-bridging oxygen atoms, the extent to which each
of them does so depends on their field strength [24].
Sodium has the lowest field strength and the lowest
percentage of NBOs in its first coordination shell and
calcium has the highest field strength and the largest
percentage of NBOs in its first coordination shell,
while strontium is intermediate between the two.
This relationship between field strength and per-
centage of NBO’s takes no account of the different
coordination numbers of the three ions. Similarly, the
amount of intra-tetrahedral bonding, where two
oxygen atoms from one PO4 tetrahedron are bonded
to the same modifier atom, varies, being most pro-
nounced in Na, and least visible in Ca, as can be seen
by the height of the peak (proportional to the amount
of intra-tetrahedral bonding) at about 60 in the O–
(Na, Ca, Sr)–O bond-angle distributions.
The network connectivity and Qn distribution are
essentially unaffected by the incorporation of stron-
tium. This is to be expected, certainly for the network
connectivity, which depends on the ratio of the
number of oxygen atoms to the number of phos-
phorus atoms, which does not change on either
SrO $ CaO or SrO $ Na2O substitution. The Qn
distribution might change, but the amounts of Sr
incorporated here are small, and so the associated
change is small.
As for other glasses with similar phosphate con-
tents [28], the dissolution rate of these glasses will be
controlled by the different bonding of the modifier
ions to the surrounding phosphate chains, which we
have characterised. Despite the differences in their
local environments in terms of coordination numbers
and percentage of non-bridging oxygen atoms in
their coordination shell, strontium and calcium bond
to a very similar number of fragments. We predict,
therefore, that SrO $ CaO will not affect the disso-
lution rate substantially. Substituting SrO for Na2O
will affect the dissolution rate, decreasing it with
increasing Sr content, as occurs when CaO substitutes
Na2O. Based on this prediction, we expect that there
will be no structural obstacles to the incorporation of
strontium into phosphate-based bioactive glasses for
biomedical implantation, and indeed, it may be pos-
sible to fine-tune the dissolution rate through careful
analysis of the SrO/CaO ratio.
Conclusion
We have conducted first-principles and classical
molecular dynamics simulations of various compo-
sitions of strontium-containing phosphate glasses, to
understand how strontium incorporation will change
the glasses’ activity when implanted into the body
(bioactivity). To perform the classical simulations, we
have developed a new interatomic potential, which
takes account of the polarizability of the oxygen ions.
Our previous work [28–30] on the dissolution of
phosphate glasses had shown us that the number of
phosphate chains chemically bound to each network
modifier is a key parameter to understand the asso-
ciated effect on the dissolution. We have found that
strontium bonds to a similar number of phosphate
chains as calcium does. The implication is that
SrO $ CaO substitution will cause little or no change
in the dissolution rate of these glasses and that the
bioactivity will remain essentially constant. We con-
clude, therefore, that strontium could be incorporated
into phosphate glass for biomedical applications.
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